-
Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage.
Cancer Res. 2012 Jan 1;72(1):13-7
PMID: 22180494
-
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Cell. 2009 Jul 23;138(2):245-56
PMID: 19632176
-
Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer.
Clin Cancer Res. 2009 Aug 1;15(15):4792-8
PMID: 19638458
-
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.
J Clin Invest. 2010 Dec;120(12):4478-92
PMID: 21099110
-
Overexpression of DNA repair genes is associated with metastasis: a new hypothesis.
Mutat Res. 2008 Jul-Aug;659(1-2):49-55
PMID: 18308619
-
Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes.
Oncogene. 2010 Nov 18;29(46):6085-98
PMID: 20818418
-
The DNA-damage response in human biology and disease.
Nature. 2009 Oct 22;461(7267):1071-8
PMID: 19847258
-
E2F1 and p53 transcription factors as accessory factors for nucleotide excision repair.
Int J Mol Sci. 2012 Oct 19;13(10):13554-68
PMID: 23202967
-
ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation.
Cancer Res. 2004 Apr 1;64(7):2390-6
PMID: 15059890
-
Punctuated evolution of prostate cancer genomes.
Cell. 2013 Apr 25;153(3):666-77
PMID: 23622249
-
Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha.
EMBO Rep. 2010 Mar;11(3):208-13
PMID: 20111054
-
Castration therapy results in decreased Ku70 levels in prostate cancer.
Clin Cancer Res. 2013 Mar 15;19(6):1547-56
PMID: 23349316
-
Modification of the DNA damage response by therapeutic CDK4/6 inhibition.
J Biol Chem. 2012 Aug 17;287(34):29075-87
PMID: 22733811
-
Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
Urol Oncol. 2009 Jan-Feb;27(1):67-71
PMID: 19111801
-
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.
Annu Rev Biochem. 2010;79:181-211
PMID: 20192759
-
Regulation of DNA double-strand break repair pathway choice.
Cell Res. 2008 Jan;18(1):134-47
PMID: 18157161
-
P53 and the proteasome regulate androgen receptor activity.
Cancer Biol Ther. 2012 May;13(7):553-8
PMID: 22407029
-
Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM.
Cancer Res. 2005 Mar 1;65(5):1670-7
PMID: 15753361
-
ARN-509: a novel antiandrogen for prostate cancer treatment.
Cancer Res. 2012 Mar 15;72(6):1494-503
PMID: 22266222
-
Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation.
Biochem Pharmacol. 2008 Oct 15;76(8):947-57
PMID: 18657518
-
Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining.
Biochem J. 2009 Feb 1;417(3):639-50
PMID: 19133841
-
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
J Clin Oncol. 2012 Apr 20;30(12):1268-73
PMID: 22393101
-
Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.
Mol Cell. 2005 Sep 2;19(5):631-42
PMID: 16137620
-
CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes.
PLoS One. 2012;7(12):e52810
PMID: 23285190
-
DNA-PKcs expression predicts response to radiotherapy in prostate cancer.
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1179-85
PMID: 22494583
-
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
Lancet. 2011 Dec 17;378(9809):2104-11
PMID: 22056152
-
Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers.
Cancer Res. 2006 Aug 15;66(16):8219-26
PMID: 16912201
-
Genomic instability--an evolving hallmark of cancer.
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
PMID: 20177397
-
Emerging roles of DNA-PK besides DNA repair.
Cell Signal. 2011 Aug;23(8):1273-80
PMID: 21514376
-
FEN1 functions in long patch base excision repair under conditions of oxidative stress in vertebrate cells.
Mol Cancer Res. 2010 Feb;8(2):204-15
PMID: 20145043
-
Targeting the DNA damage response in oncology: past, present and future perspectives.
Curr Opin Oncol. 2012 May;24(3):316-24
PMID: 22476188
-
The RAD51 gene family, genetic instability and cancer.
Cancer Lett. 2005 Mar 10;219(2):125-35
PMID: 15723711
-
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
Cancer Res. 2008 Jun 1;68(11):4447-54
PMID: 18519708
-
Abiraterone in prostate cancer: a new angle to an old problem.
Clin Cancer Res. 2012 Apr 1;18(7):1848-54
PMID: 22451619
-
Playing the end game: DNA double-strand break repair pathway choice.
Mol Cell. 2012 Aug 24;47(4):497-510
PMID: 22920291
-
Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha.
Mol Biol Cell. 2010 May 1;21(9):1620-8
PMID: 20219974
-
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Nature. 2005 Apr 14;434(7035):864-70
PMID: 15829956
-
Genomic instability and cancer: an introduction.
J Mol Cell Biol. 2011 Feb;3(1):1-3
PMID: 21278445
-
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.
Oncogene. 2012 Apr 26;31(17):2153-63
PMID: 21909140
-
Targeted therapies for breast cancer.
J Clin Invest. 2011 Oct;121(10):3797-803
PMID: 21965336
-
Targeting androgen receptor in estrogen receptor-negative breast cancer.
Cancer Cell. 2011 Jul 12;20(1):119-31
PMID: 21741601
-
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.
Cancer Res. 2006 May 15;66(10):5354-62
PMID: 16707462
-
Use of γH2AX and other biomarkers of double-strand breaks during radiotherapy.
Semin Radiat Oncol. 2010 Oct;20(4):223-31
PMID: 20832014
-
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.
World J Gastroenterol. 2008 Oct 21;14(39):5945-61
PMID: 18932272
-
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
Lancet. 2009 Jan 24;373(9660):301-8
PMID: 19091394
-
Radiation-induced genomic instability and its implications for radiation carcinogenesis.
Oncogene. 2003 Sep 1;22(37):5848-54
PMID: 12947391
-
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.
Nucl Recept Signal. 2008 Jun 27;6:e008
PMID: 18612376
-
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Cancer Res. 2007 Jul 1;67(13):6192-203
PMID: 17616676
-
Lack of prostate cancer radiosensitization by androgen deprivation.
Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):1002-7
PMID: 11704324
-
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
N Engl J Med. 1997 Jul 31;337(5):295-300
PMID: 9233866
-
Chromatin modifications and the DNA damage response to ionizing radiation.
Front Oncol. 2013 Jan 22;2:214
PMID: 23346550
-
Chicken progesterone receptor is phosphorylated by a DNA-dependent protein kinase during in vitro transcription assays.
Mol Endocrinol. 1992 Jan;6(1):8-14
PMID: 1738374
-
The DNA damage response: making it safe to play with knives.
Mol Cell. 2010 Oct 22;40(2):179-204
PMID: 20965415
-
Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells.
J Biol Chem. 1998 Aug 7;273(32):20213-22
PMID: 9685369
-
Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks.
J Biol Chem. 2005 Apr 15;280(15):14709-15
PMID: 15677476
-
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
Cancer Res. 2008 Jul 1;68(13):5469-77
PMID: 18593950
-
Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Mol Endocrinol. 2012 Aug;26(8):1252-67
PMID: 22745190
-
Dual roles of PARP-1 promote cancer growth and progression.
Cancer Discov. 2012 Dec;2(12):1134-49
PMID: 22993403
-
Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks.
Genes Dev. 2002 Sep 15;16(18):2333-8
PMID: 12231622
-
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
Cancer Cell. 2010 May 18;17(5):443-54
PMID: 20478527
-
A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
Science. 2006 Jun 23;312(5781):1798-802
PMID: 16794079
-
DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability.
Prog Nucleic Acid Res Mol Biol. 1988;35:95-125
PMID: 3065826
-
Formation of the androgen receptor transcription complex.
Mol Cell. 2002 Mar;9(3):601-10
PMID: 11931767
-
Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86.
Br J Cancer. 2009 Sep 1;101(5):816-21
PMID: 19672258
-
Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.
J Biol Chem. 2005 Mar 18;280(11):10827-33
PMID: 15640154
-
Targeting the androgen receptor pathway in prostate cancer.
Curr Opin Pharmacol. 2008 Aug;8(4):440-8
PMID: 18674639
-
Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma.
Radiat Res. 2010 Dec;174(6):703-11
PMID: 21128793
-
The life and death of DNA-PK.
Oncogene. 2005 Feb 3;24(6):949-61
PMID: 15592499
-
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.
Cancer Cell. 2013 Jan 14;23(1):35-47
PMID: 23260764
-
Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Science. 2009 May 8;324(5928):787-90
PMID: 19359544
-
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
Nature. 2005 Apr 14;434(7035):907-13
PMID: 15829965